Bioinformation Therapy for Pancreatic Cancer

Status Completed

Clinical Trial Summary

The aim of this study is the synergistic effect of cancer ablation and life information rehabilitation therapy on unresectable pancreatic cancer.

Clinical Trial Description

By enrolling patients with unresectable pancreatic cancer adapted to enrolled criteria, this study will document for the first time the synergistic effect of cancer ablation and life information rehabilitation therapy. The efficacy will be evaluated according to local relief degree, progress free survival (PFS) and overall survival (OS). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03239184
Study type	Interventional
Source	Fuda Cancer Hospital, Guangzhou
Contact
Status	Completed
Phase	Phase 2/Phase 3
Start date	September 1, 2017
Completion date	September 1, 2018

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT02495896` - Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors	Phase 1
Not yet recruiting	`NCT02945267` - Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer	Phase 4
Completed	`NCT01304160` - Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic Cancer	Phase 1/Phase 2
Withdrawn	`NCT05251038` - Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer	Phase 1/Phase 2
Completed	`NCT03602885` - EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options	N/A
Recruiting	`NCT04002479` - Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer	N/A
Recruiting	`NCT03063554` - EUS BD vs ERCP TP for Pancreatic Cancer	N/A
Completed	`NCT03250273` - A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma	Phase 2
Not yet recruiting	`NCT06099119` - Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.	Phase 4
Completed	`NCT02035072` - Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer.	Phase 2
Terminated	`NCT04698915` - Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer	Phase 2
Recruiting	`NCT04789486` - Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer	Phase 1/Phase 2
Active, not recruiting	`NCT03138720` - Pre-operative Treatment for Patients With Untreated Pancreatic Cancer	Phase 2
Recruiting	`NCT04395469` - FAZA PET/MRI Pancreas	N/A
Recruiting	`NCT04093141` - Chemotherapy Followed by Irreversible Electroporation in Patients With Unresectable Locally Advanced Pancreatic Cancer	N/A
Not yet recruiting	`NCT06278454` - Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC)	Phase 1
Terminated	`NCT02166190` - RFA RCT for Pancreatic or Bile Duct Cancer	N/A
Completed	`NCT02282722` - Improving Informed Consent for Palliative Chemotherapy	N/A
Recruiting	`NCT05601323` - A Study of Suizenji in Patients With Unresectable Pancreatic Cancer	N/A
Not yet recruiting	`NCT06026943` - Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer	N/A